Department of Cardiovascular Disease, Shinshu University Graduate School of Medicine, Japan.
Department of Cardiovascular Disease, Shinshu University Graduate School of Medicine, Japan.
J Mol Cell Cardiol. 2014 Dec;77:73-85. doi: 10.1016/j.yjmcc.2014.09.017. Epub 2014 Sep 28.
Adrenomedullin (AM) is a vasoactive peptide that possesses various bioactivities. AM receptors are dimers consisting of CLR with one of two accessory proteins, RAMP2 or RAMP3. The functional difference between CLR/RAMP2 and CLR/RAMP3 and the relationship between the two receptors remain unclear. To address these issues, we generated RAMP2 and RAMP3 knockout (-/-) mice and have been studying their physiological activities in the vascular system. AM-/- and RAMP2-/- mice die in utero due to blood vessel abnormalities, which is indicative of their essential roles in vascular development. In contrast, RAMP3-/- mice were born normally without any major abnormalities. In adult RAMP3-/- mice, postnatal angiogenesis was normal, but lymphangiography using indocyanine green (ICG) showed delayed drainage of subcutaneous lymphatic vessels. Moreover, chyle transport by intestinal lymphatics was delayed in RAMP3-/- mice, which also showed more severe interstitial edema than wild-type mice in a tail lymphedema model, with characteristic dilatation of lymphatic capillaries and accumulation of inflammatory cells. In scratch-wound assays, migration of isolated RAMP3-/- lymphatic endothelial cells was delayed as compared to wild-type cells, and AM administration failed to enhance the re-endothelialization. The delay in re-endothelialization was due to a primary migration defect rather than a decrease in proliferation. These results suggest that RAMP3 regulates drainage through lymphatic vessels, and that the AM-RAMP3 system could be a novel therapeutic target for controlling postoperative lymphedema.
肾上腺髓质素(AM)是一种具有多种生物活性的血管活性肽。AM 受体由 CLR 与两种辅助蛋白之一 RAMP2 或 RAMP3 组成的二聚体构成。CLR/RAMP2 和 CLR/RAMP3 之间的功能差异以及这两种受体之间的关系尚不清楚。为了解决这些问题,我们生成了 RAMP2 和 RAMP3 敲除(-/-)小鼠,并一直在研究它们在血管系统中的生理活性。由于血管异常,AM-/-和 RAMP2-/-小鼠在子宫内死亡,这表明它们在血管发育中具有重要作用。相比之下,RAMP3-/-小鼠正常出生,没有任何重大异常。在成年 RAMP3-/-小鼠中,产后血管生成正常,但使用吲哚菁绿(ICG)进行淋巴管造影显示皮下淋巴管引流延迟。此外,RAMP3-/-小鼠的肠道淋巴管乳糜转运延迟,在尾淋巴水肿模型中比野生型小鼠表现出更严重的间质水肿,其特征为淋巴管毛细血管扩张和炎症细胞积聚。在划痕实验中,与野生型细胞相比,分离的 RAMP3-/-淋巴管内皮细胞的迁移延迟,而 AM 给药未能增强再内皮化。再内皮化的延迟是由于原发性迁移缺陷而不是增殖减少。这些结果表明 RAMP3 调节通过淋巴管的引流,并且 AM-RAMP3 系统可能是控制术后淋巴水肿的新的治疗靶点。